Retention of p53val135 Wild-Type Function in Transgenic Mice

Laboratory Investigation

Volumn 74, Issue 6, 1996, Pages 1005-1011

  Schaffner, David L ^a   Chévez Barrios, Patricia ^a   Huang, Shiu L ^a   Barrios, Roberto ^a   Dickey, Burton F ^a   Shaker, Mohammad R ^a,b   Rajagopalan, Sridharan ^a   Habib, Geetha M ^a   Lebovitz, Russell M ^a   Lieberman, Michael W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GAMMA GLUTAMYLTRANSFERASE; PROTEIN P53; RNA; VALINE;

ANIMAL; ARTICLE; GENETICS; MOLECULAR GENETICS; MOUSE; MUTATION; NUCLEOTIDE SEQUENCE; ONCOGENE RAS; TRANSGENE; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; DISEASE SEVERITY; GENE EXPRESSION REGULATION; GENE MUTATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION;

ALANINE; ANIMALS; BASE SEQUENCE; GAMMA-GLUTAMYLTRANSFERASE; GENES, P53; GENES, RAS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTATION; RNA; TRANSGENES; TUMOR SUPPRESSOR PROTEIN P53; VALINE;

EID: 0029665521     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Beato M (1989). Gene regulation by steroid hormones. Cell 56:335-344.
2. Brooks JD, Bova GS, Marshall FF, and Isaacs WB (1993). Tumor suppressor gene allelic loss in human renal cancers. J Urol 150:1278-1283.
3. Bruner JM, Connelly JH, and Saya H (1993). p53 protein immunostaining in routinely processed paraffin-embedded sections. Mod Pathol 6:189-194.
4. Chévez-Barrios P, Schaffner DL, Barrios R, Overbeek PA, Lebovitz RM, and Lieberman MW (1993). Expression of the rasT24 oncogene in the ciliary body pigment epithelium and retinal pigment epithelium results in hyperplasia, adenoma, and adenocarcinoma. Am J Pathol 143:20-28.
5. Chomczynski P and Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 162:156-159.
6. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, and Bradley A (1992). Mice deficient for p553 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-221.
7. Eliyahu D, Michalovitz D, and Oren M (1985). Overproduction of p53 antigen makes established cells highly tumorigenic. Nature 316:158-160.
8. Eliyahu D, Raz A, Gruss P, Givol D, and Oren M (1984). Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature 312:646-649.
9. Foster K, Crossey PA, Cairns P, Hetherington JW, Richards FM, Jones MH, Bentley E, Affara NA, Ferguson-Smith MA, and Maher ER (1994). Molecular genetic investigation of sporadic renal cell carcinoma: Analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22. Br J Cancer 69:230-234.
10. Hinds P, Finlay C, and Levine AJ (1989). Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J Virol 63:739-746.
11. Hogan B, Costantini F, and Lacy E (1986). Manipulating the mouse embryo. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory.
12. Hollstein M, Sidransky D, Vogelstein B, and Harris CC (1991). p53 mutations in human cancers. Science 253:49-53.
13. Kawasaki ES (1990). Amplification of RNA. In Innis MA, Gelfand DH, Sninsky JJ, and White TJ, editors. PCR protocols: A guide to methods and applications. San Diego: Adacemic Press, 21-27.
14. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
15. Lane DP and Benchimol S (1990). p53: Oncogene or anti-oncogene? Genes Dev 4:1-8.
16. Lavigueur A, Maltby V, Mock D, Rossant J, Pawson T, and Bernstein A (1989). High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cel Biol 9:3982-3991.
17. Levine AJ (1990). Tumor suppressor genes. Bioessays 12: 60-66.
18. Levine AJ, Perry ME, Chang A, Silver A, Dittmer D, Wu M, and Welsh D (1994). The 1993 Walter Hubert lecture: The role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer 69:409-416.
19. Lipponen P, Eskelinen M, Hietala K, and Syrjanen K (1994). Expression of proliferating cell nuclear antigen (PC10), p53 protein and c-enbB-2 in renal adenocarcinoma. Int J Cancer 57:275-280.
20. Lozano G and Levine AJ (1991). Tissue-specific expression of p53 in transgenic mice is regulated by intron sequences. Mol Carcinogen 4:3-9.
21. Malkin D, Li FP, Strong LC, Fraumeme JF Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, and Tainsky MA (1990). Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-1238.
22. Michalovitz D, Halevy O, and Oren M (1990). Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671-680.
23. Ogawa O, Habuchi T, Kakehi Y, Koshiba M, Sugiyama T, and Yoshida O (1992). Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p. Cancer Res 52:1881-1885.
24. Oka K, Ishikawa J, Bruner JM, Takahashi R, and Saya H (1991). Detection of loss of heterozygosity in the p53 gene in renal cell carcinoma and bladder cancer using the polymerase chain reaction. Mol Carcinogen 4:10-13.
25. Overbeek PA, Aguilar-Cordova E, Hanten G, Schaffner DL, Patel P, Lebovitz RM, and Lieberman MW (1991). A coinjection strategy for visual identification of transgenic mice. Transgen Res 1:31-37.
26. Parada LF, Land H, Weinberg RA, Wolf D, and Rotter V (1984). Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature 312:649-651.
27. Pinhasi O and Oren M (1984). Expression of the mouse p53 cellular tumor antigen in monkey cells. Mol Cell Biol 4:2180-2186.
28. Rajagopalan S, Park JH, Patel PD, Lebovitz RM, and Lieberman MW (1990). Cloning and analysis of the rat γ-glutamyl transferase gene. J Biol Chem 265:11721-11725.
29. Reiter RE, Anglard P, Liu S, Gnarra JR, and Linehan WM (1993). Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Cancer Res 53:3092-3097.
30. Sambrook J, Fritsch EF, and Maniatis T (1989). Molecular cloning: A laboratory manual, 2nd ed. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
31. Schaffner DL, Barrios R, Massey C, Bañez EI, Ou CN, Rajagopalan S, Aguilar-Cordova E, Lebovitz RM, Overbeek PA, and Lieberman MW (1993). Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys. Am J Pathol 142:1051-1060.
32. Uchida T, Wada C, Shitara T, Egawa S, Mashimo S, and Koshiba K (1993). Infrequent involvement of p53 mutations and loss of heterozygosity of 17p in the tumorigenesis of renal cell carcinoma. J Urol 150:1298-1301.
33. Vogelstein B (1990). A deadly inheritance. Nature 348:681-682.
34. Weinberg RA (1991). Tumor suppressor genes. Science 254:1138-1146.
35. Yokoyama T, Silversides DW, Waymire KG, Kwon BS, Takeuchi T, and Overbeek PA (1990). Conserved cysteine to serine mutation in tyrosinase is responsible for the classical albino mutation in laboratory mice. Nucleic Acids Res 18:7293-7298.